Cargando…

Higher Plasma Pentraxin-3 Level Predicts Adverse Clinical Outcomes in Patients With Coronary Artery Disease: A Meta-Analysis of Cohort Studies

Background: Association between plasma pentraxin-3 (PTX-3) and clinical outcomes in patients with coronary artery disease (CAD) remains not fully determined. An updated meta-analysis of cohort studies was performed to systematically evaluate the association. Methods: Cohort studies evaluating the as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Kejun, Shi, Zhewei, Qian, Caizhen, Yang, Xuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785244/ https://www.ncbi.nlm.nih.gov/pubmed/35083296 http://dx.doi.org/10.3389/fcvm.2021.726289

Ejemplares similares

Associations between pentraxin 3 and severity of coronary artery disease
por: Liu, Hua, et al.
Publicado: (2015)

Utility of Elevated Pentraxin-3 Level as Inflammatory Marker for Predicting Adverse Outcomes in Patients With Acute Coronary Syndrome: A Meta-Analysis
por: Fan, Yu, et al.
Publicado: (2022)

Plasma osteoprotegerin predicts adverse cardiovascular events in stable coronary artery disease: the PEACE trial
por: Ma, Teng, et al.
Publicado: (2023)

Directly Measured vs. Calculated Low-Density Lipoprotein Cholesterol Does Not Identify Additional Individuals With Coronary Artery Disease and Diabetes at Higher Risk of Adverse Events: Insight From a Large Percutaneous Coronary Intervention Cohort in Asia
por: Shi, Boqun, et al.
Publicado: (2022)

Relation Between Plasma Proteomics Analysis and Major Adverse Cardiovascular Events in Patients With Stable Coronary Artery Disease
por: Dregoesc, Mihaela Ioana, et al.
Publicado: (2022)

Atherogenic Index of Plasma and Coronary Artery Disease in the Adult Population: A Meta-Analysis
por: Wu, Jing, et al.
Publicado: (2021)

Corrigendum: Atherogenic index of plasma and coronary artery disease in the adult population: A meta-analysis
por: Wu, Jing, et al.
Publicado: (2023)

Plasma Big Endothelin-1 Level Predicted 5-Year Major Adverse Cardiovascular Events in Patients With Coronary Artery Ectasia
por: Cai, Zhongxing, et al.
Publicado: (2021)

Prognostic Significance of Triglyceride-Glucose Index for Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis
por: Luo, Jin-Wen, et al.
Publicado: (2021)

Patency and adverse outcomes of sequential vs. individual saphenous vein grafts in coronary artery bypass: A meta-analysis
por: Jiao, He, et al.
Publicado: (2022)

Impact of premature coronary artery disease on adverse event risk following first percutaneous coronary intervention
por: Pinxterhuis, Tineke H., et al.
Publicado: (2023)

Association Between Circulating Retinol-Binding Protein 4 and Adverse Cardiovascular Events in Stable Coronary Artery Disease
por: Qian, Ke, et al.
Publicado: (2022)

Predictive Value of Plasma Big Endothelin-1 in Adverse Events of Patients With Coronary Artery Restenosis and Diabetes Mellitus: Beyond Traditional and Angiographic Risk Factors
por: Ma, Yue, et al.
Publicado: (2022)

Association between low-density lipoprotein cholesterol level and mortality in patients with cardiogenic shock: a retrospective cohort study
por: Jin, Jiali, et al.
Publicado: (2021)

Correlation Between Plasma Proteomics and Adverse Outcomes Among Older Men With Chronic Coronary Syndrome
por: Cai, Yu-Lun, et al.
Publicado: (2022)

Prognostic value of plasma adipokine chemerin in patients with coronary artery disease
por: Wang, Bo, et al.
Publicado: (2022)

Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease: A One-Stage Meta-Analysis
por: Chew, Nicholas W. S., et al.
Publicado: (2022)

Risk factors for major adverse cardiovascular events after coronary artery bypass grafting using radial artery grafts
por: Xia, Tianyu, et al.
Publicado: (2023)

The role of blood CXCL12 level in prognosis of coronary artery disease: A meta-analysis
por: Zhang, Shunrong, et al.
Publicado: (2022)

The atherogenic index of plasma (AIP) is a predictor for the severity of coronary artery disease
por: Li, Ya, et al.
Publicado: (2023)

Comparing the pooled cohort equations and coronary artery calcium scores in a symptomatic mixed Asian cohort
por: Baskaran, Lohendran, et al.
Publicado: (2023)

Plasma Oxylipins: A Potential Risk Assessment Tool in Atherosclerotic Coronary Artery Disease
por: Le, D. Elizabeth, et al.
Publicado: (2021)

Shexiang Baoxin Pill (MUSKARDIA) reduces major adverse cardiovascular events in women with stable coronary artery disease: A subgroup analysis of a phase IV randomized clinical trial
por: Shi, Haiming, et al.
Publicado: (2022)

Famine in childhood and postmenopausal coronary artery calcification: a cohort study
por: Idris, Nikmah S, et al.
Publicado: (2013)

The Prognostic Value of Reticulated Platelets in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis
por: Zhao, Yihan, et al.
Publicado: (2020)

Effect of Alirocumab on Coronary Calcification in Patients With Coronary Artery Disease
por: Gao, Fei, et al.
Publicado: (2022)

Association of plasma propionate concentration with coronary artery disease in a large cross-sectional study
por: Pagonas, Nikolaos, et al.
Publicado: (2023)

Five-years’ prognostic analysis for coronary artery ectasia patients with coronary atherosclerosis: A retrospective cohort study
por: Liu, Ruifeng, et al.
Publicado: (2022)

Coronary Artery Calcification Under Statin Therapy and Its Effect on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
por: Lai, Runmin, et al.
Publicado: (2020)

Evaluation of 71 Coronary Artery Disease Risk Variants in a Multiethnic Cohort
por: Ke, Wangjing, et al.
Publicado: (2018)

Sleep Quality, Sleep Duration, and the Risk of Adverse Clinical Outcomes in Patients With Myocardial Infarction With Non-obstructive Coronary Arteries
por: Zhu, Chun-Yan, et al.
Publicado: (2022)

Cohort profile: the Coronary Artery disease Risk Determination In Innsbruck by diaGnostic ANgiography (CARDIIGAN) cohort
por: Wanitschek, Maria, et al.
Publicado: (2018)

A Meta-Analysis Evaluating the Colchicine Therapy in Patients With Coronary Artery Disease
por: Grajek, Stefan, et al.
Publicado: (2021)

Plasma type I collagen α1 chain in relation to coronary artery disease: findings from a prospective population-based cohort and an acute myocardial infarction prospective cohort in Sweden
por: Hammaréus, Filip, et al.
Publicado: (2023)

New adverse coronary events in valve-in-valve TAVR and native TAVR—A 2-year matched cohort
por: Koren, Ofir, et al.
Publicado: (2022)

Serum YKL-40 in coronary heart disease: linkage with inflammatory cytokines, artery stenosis, and optimal cut-off value for estimating major adverse cardiovascular events
por: Song, Mowei, et al.
Publicado: (2023)

A Left Ventricular Mechanical Dyssynchrony-Based Nomogram for Predicting Major Adverse Cardiac Events Risk in Patients With Ischemia and No Obstructive Coronary Artery Disease
por: Zhang, Han, et al.
Publicado: (2022)

The clinical impact of serum 1,5-anhydro-D-glucitol levels on coronary artery calcification and adverse outcomes assessed by coronary optical coherence tomography in diabetic patients
por: Teng, Hsin-I, et al.
Publicado: (2022)

Incident Heart Failure in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Gu, Jun, et al.
Publicado: (2021)

Association between psoriasis and coronary artery calcification: A systematic review and meta-analysis
por: Wu, Huihui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h01uv5k2f5hr7j81du9hvs3dou